Loading...

We are the Peptide Experts


JPT Peptide Technologies is the leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. For more than 15 years we have been serving the worldwide biomedical community with science and quality driven products and services.

Located in our state-of-the-art laboratories in Berlin, Germany, JPT operates according to the most recent ISO 9001:2015 regulations.


Custom Peptide Synthesis


Product Finder

Search by scientific field

Research Fields

Cell Therapy & Vaccines

Cell Therapy & Vaccines

JPT offers a large portfolio of peptide products and services supporting all development phases of new cell therapies and vaccines. These products range from discovery tools for epitope and target identification, to various peptide formats for immune monitoring and clinical grade peptides to support clinical vaccination and cell therapy trials.  Learn more
Immunology

Immunology

JPT has developed a variety of unique peptide-based products allowing systematic evaluation of cellular and humoral immunity. In addition to peptide formats allowing T-cell and B-cell epitope discovery, antigen-specific T-cell stimulation and immune monitoring our clinical grade products support clinical trials for the development of new immunotherapeutics and vaccines. Learn more
Neo-Epitope Discovery & Therapy

Neo-Epitope Discovery & Therapy

Neo-epitopes are important targets for individualized cancer immunotherapy. JPT’s high-throughput peptide techniques enable access to customized peptide products for neo-epitope prioritization and validation, individualized therapy development and immune monitoring. Learn more
Proteomics

Proteomics

Proteomics is the study of a cell's protein inventory at different times by protein identification and quantification. The application of mass spectrometry and more specifically LC-MS/MS has tremendously facilitated this process. JPT developed proprietary approaches for the provision of quantified custom peptides and ready-to-use products enabling protein biomarker identification and quantitation. Learn more
COVID-19

COVID-19

JPT was the first company responding to the Covid-19 pandemic with the launch of a broad SARS CoV-2 genome spanning portfolio of peptide tools. The ready to use and custom peptide tools include antigen spanning PepMixTM peptide pools and PepStarTM peptide microarrays of SARS-CoV-2 wild type and mutated antigen sequences as well as antigens from other relevant corona viruses.  Learn more
Loading...

News

Recent Publications on Infectious Diseases
JPT offers a broad range of innovative peptide products that cover antigens of many known viruses and bacteria. Here we demonstrate the range of our catalog and customizable products on the basis of recent publications:

May 2022
Check Out Our New Fully Purified Omicron Pools!
With the recent release of our PepMix SARS-CoV-2 Omicron BA.1 products covering the entire spike glycoprotein and the RB-domain, we are now announcing the addition of fully purified versions:
  • PepMix SARS-CoV-2 (Spike / BA.1 / Omicron)
  • PepMix SARS-CoV-2 (S-RBD / BA.1 / Omicron)
May 2022
Our new US-based peptide expert – Aude-Marie Alem
We would like to introduce you to the latest member of our US-based Business Development team at JPT, Aude-Marie Alem. Now, from her new home base in Cambridge, Massachusetts, she is able to continue her work and additionally provide in-person support via technical seminars and visits to your labs.
April 2022

Check our list of products, click and go.

Get a quote